A new underground industry has emerged where people are buying raw compounds for Ozempic, Botox, filler and skin-tightening treatments directly from Chinese suppliers — and injecting them at ...

Remembering French actor and animal activist Brigitte Bardot With the penny going away, what should you do with the ones in your coin jar? FBI releases images of seized motorcycles as search for Ryan ...

Long-term data published in JAMA Neurology further illustrate the effects of Biogen’s QALSODY on function, strength, and survival in SOD1-ALS Over 3 years, a subset of QALSODY-treated participants ...

Quick and easy brazilian wax tutorial!! President Trump signs executive order reclassifying marijuana Los Angeles Rams star Puka Nacua performs antisemitic touchdown dance on livestream Men’s lazy ...

The U.S. Food and Drug Administration is reportedly weighing whether it will place a “black box” warning label on COVID vaccines, according to CNN, despite research and real-world data demonstrating ...

Medical devices that minimize procedure times and contamination risks and that ease end-use offer numerous benefits to patients and healthcare systems. Our webinar, “Engineering Advanced Medical ...

November trial date set for man accused of murdering son, girlfriend A tentative November trial date has been set for a man accused of killing his son and girlfriend.David Huff is facing three charges ...

Syracuse, NY — The firm picked by state officials to design Upstate University Hospital’s new $450 million emergency room annex has roots in Buffalo and has a wealth of hospital experience.

Vraylar (cariprazine) is a powerful antipsychotic medication that is approved by the Food and Drug Administration (FDA) to treat schizophrenia, bipolar disorder, and major depressive disorder (MDD).

A new sociomedical perspective shows how off-label use of GLP-1 drugs for slimness is redefining what counts as a healthy, responsible body, revealing hidden moral pressures and global inequalities ...

Products are getting smaller in the world and therefore getting harder to make, shares John Kawola, CEO of Boston Micro Fabrication (BMF). Demand for technical solutions is high in the medtech field ...